Glossaries Addiction Expand Secondary Navigation Menu Recovery Expand Secondary Navigation Menu 12 Step talk Alzheimer's Autism Disability ECT Forensic HIPAA Memory OCD Pharmacology Expand Secondary Navigation Menu Psychopharmacology Psychopathology Psychotherapy Expand Secondary Navigation Menu ABA Adlerian Cognitive Behavior Therapy EMDR Family Gestalt IFS Jungian MI Narrative NLP PCT Psychoanalytic Psychodynamic TA Unified Psychotherapy RDoC Reimbursement Sleep Medicine Expand Secondary Navigation Menu Chronobiology EEG Polysomnography Stuttering TMS Treatment VNS Connect with us Become a fan on Facebook Follow us on X Subscribe (sample) to our Newsletter Follow us on Pinterest Revex nalmefene Company Baxter FDA Label Indications 04/17/1995 complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids. 12/31/1969 management of known or suspected opioid overdose. Companies Baxter Molecular entities nalmefene Daily Posts CNS Drug: #CNSDODNotable Person: #BHCPODPhobia: #BNphobiaTerm: #BHCTOD National Conference #Hashtags 11/12-14 AMERSA#AMERSA202611/12-15 AAAP#AAAP202611/12-15 ABCT#ABCTNOW11/14-18 SfN#SfN2611/18-21 ACLP#ACLP2026
